Tokyo Tape
Sign in
← Takeda Pharmaceutical

Quarterly report · Q1

4502.TEDINET S100OU39
Period2022-04-01 → 2022-06-30
Filed2022-08-04
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥972.5bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Revenue¥3.57T2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥949.6bn2021-04-01 → 2021-06-30Cons.Revenue IFRS
Operating income¥150.5bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Operating income¥248.6bn2021-04-01 → 2021-06-30Cons.Operating profit loss IFRS
Profit before tax¥155.5bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Profit before tax¥302.6bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥223.0bn2021-04-01 → 2021-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥105.0bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥230.1bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥137.7bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥105.0bn2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Net income¥230.2bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥137.7bn2021-04-01 → 2021-06-30Cons.Profit loss IFRS
Total assets¥14.07Tat 2022-06-30Cons.Assets IFRS
Total assets¥13.18Tat 2022-03-31Cons.Assets IFRS
Total assets¥12.66Tat 2021-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥7.75Tat 2022-06-30Cons.Liabilities IFRS
Total liabilities¥7.49Tat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥6.32Tat 2022-06-30Cons.Equity IFRS
Net assets / equity¥5.68Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥5.24Tat 2021-06-30Cons.Equity IFRS
Net assets / equity¥5.18Tat 2021-03-31dCons.Equity IFRS
Equity (owners)¥6.32Tat 2022-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥5.68Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥646.0bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥849.7bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥654.9bnat 2021-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥966.2bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥84.2bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥1.12T2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥166.9bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥94.7bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥198.1bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥70.4bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥215.7bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥1.07T2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥411.0bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥67.942022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥147.142021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥87.962021-04-01 → 2021-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥67.562022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥145.872021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥87.452021-04-01 → 2021-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio44.9%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio43.1%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio41.4%at 2021-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 624
ItemContextValueUnit
Comprehensive income IFRSCurrentYTDDuration_TreasurySharesIFRSMember－JPY
Comprehensive income IFRSCurrentYTDDuration_RetainedEarningsIFRSMember105014000000JPY
Comprehensive income IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember722137000000JPY
Comprehensive income IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-225000000JPY
Issuance of new shares ss IFRSCurrentYTDDuration_ShareCapitalIFRSMember14000000JPY
Issuance of new shares ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember14000000JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember-5000000JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_TreasurySharesIFRSMember-27045000000JPY
Dividends ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember-138218000000JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember15213000000JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-4679000000JPY
Share based compensation ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember12292000000JPY
Exercise of share based awards ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember-13838000000JPY
Exercise of share based awards ss IFRSCurrentYTDDuration_TreasurySharesIFRSMember13867000000JPY
Total transactions with owners IFRSCurrentYTDDuration_ShareCapitalIFRSMember14000000JPY
Total transactions with owners IFRSCurrentYTDDuration_CapitalSurplusIFRSMember-1537000000JPY
Total transactions with owners IFRSCurrentYTDDuration_TreasurySharesIFRSMember-13177000000JPY
Total transactions with owners IFRSCurrentYTDDuration_RetainedEarningsIFRSMember-123005000000JPY
Total transactions with owners IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Total transactions with owners IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-4679000000JPY
Equity IFRSCurrentQuarterInstant_ShareCapitalIFRSMember1676277000000JPY
Equity IFRSCurrentQuarterInstant_CapitalSurplusIFRSMember1707336000000JPY
Equity IFRSCurrentQuarterInstant_TreasurySharesIFRSMember-129184000000JPY
Equity IFRSCurrentQuarterInstant_RetainedEarningsIFRSMember1459764000000JPY
Equity IFRSCurrentQuarterInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember1710399000000JPY
Equity IFRSCurrentQuarterInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember17163000000JPY
Equity IFRSPrior1YearInstant_EffectivePortionOfCashFlowHedgesIFRSMember-65901000000JPY
Equity IFRSPrior1YearInstant_jpcrp040300-q1r_E00919-000HedgingCostIFRSMember-6135000000JPY
Equity IFRSPrior1YearInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Equity IFRSPrior1YearInstant_OtherComponentsOfEquityIFRSMember934173000000JPY
Equity IFRSPrior1YearInstant_EquityAttributableToOwnersOfParentIFRSMember5683019000000JPY
Equity IFRSPrior1YearInstant_NonControllingInterestsIFRSMember504000000JPY
Equity IFRSPrior1YearInstant5683523000000JPY
Effect of hyperinflation IFRSPrior1YearInstant_OtherComponentsOfEquityIFRSMember4121000000JPY
Effect of hyperinflation IFRSPrior1YearInstant_EquityAttributableToOwnersOfParentIFRSMember2161000000JPY
Effect of hyperinflation IFRSPrior1YearInstant2161000000JPY
Restated balance IFRSPrior1YearInstant_EffectivePortionOfCashFlowHedgesIFRSMember-65901000000JPY
Restated balance IFRSPrior1YearInstant_jpcrp040300-q1r_E00919-000HedgingCostIFRSMember-6135000000JPY
Restated balance IFRSPrior1YearInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Restated balance IFRSPrior1YearInstant_OtherComponentsOfEquityIFRSMember938294000000JPY
Restated balance IFRSPrior1YearInstant_EquityAttributableToOwnersOfParentIFRSMember5685180000000JPY
Restated balance IFRSPrior1YearInstant_NonControllingInterestsIFRSMember504000000JPY
Restated balance IFRSPrior1YearInstant5685684000000JPY
Profit loss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Profit loss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember105014000000JPY
Profit loss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember7000000JPY
Profit loss IFRSCurrentYTDDuration105021000000JPY
Other comprehensive income IFRSCurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember-25473000000JPY
Other comprehensive income IFRSCurrentYTDDuration_jpcrp040300-q1r_E00919-000HedgingCostIFRSMember-27415000000JPY
Other comprehensive income IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember10533000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass